Target No. 1
HEART | LUNG Many Temple researchers focus on the cellular and molecular mechanisms of heart disease. Their insights into the biology of the heart are opening doors for more targeted treatments—from novel pharmaceuticals and biologicals to therapies with genes, RNA interference, stem cells, and devices. Our faculty based at the Cardiovascular Research Center, the Center for Translational Medicine, the Thrombosis Research Center, and the Center for Metabolic Disease pursue research in heart muscle disease, vascular biology, transplant immunology, drug cardiotoxicity, venous thrombosis, hemorrhagic and inflammatory diseases, tumor angiogenesis, personalized medicine, and long-term disease management. Our pulmonary researchers, working out of the Center for Inflammation, Translational, and Clinical Lung Research, specialize in deciphering the inflammatory and immune aspects of chronic and acute lung diseases. Their goal is to develop novel therapeutics and interventions to slow or reverse diseases such as chronic obstructive pulmonary disease, asthma, lung cancer, pulmonary fibrosis, and pulmonary hypertension. The Temple Lung Center, one of the country’s top pulmonary referral and research centers, works closely with researchers at Temple and at other institutions to offer dozens of clinical trial opportunities to patients every year. Today, over 100 faculty, fellows, and graduate students are engaged in translational cardiovascular or pulmonary research at Temple Health. Our primary lines of research are sketched on the following pages.
HEART | LUNG
7